Alterity has secured the worldwide exclusive right to patented technology to develop and commercialise therapies that re-sensitise bacteria to antibiotics
If validated, the discovery by St Jude scientists could offer real tools to deal with hyperinflammatory immune responses, one of the leading causes of death in Covid-19 infections
Based on the available scientific evidence and current clinical experience, the SPR Collaboration recommends that physicians and authorities consider the following Covid-19 treatment protocol for the early treatment of people at high risk or high exposure